$250 | Single User
$500 | Site License
$750 | Global License

Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

Published by Global Data: 16 Oct 2018 | 225504 | In Stock

Introduction

Summary

Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune disorders, infectious, respiratory and women's diseases, and diabetes. The company provides animal health products including vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. Outside the US, the company operates through subsidiaries. It operates in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.

Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 6

    List of Figures 7

    Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

    Merck & Co Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

    Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

    Merck & Co Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11

    Merck & Co Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

    Merck & Co Inc, Medical Equipment, Deal Details 18

    Venture Financing 18

    Grail Raises USD914 Million in First Tranche of Series B Financing 18

    Livongo Health Raises USD44.5 Million in Series C Financing Round 21

    WellDoc Raises USD22 Million in First Tranche of Series B Financing 23

    CareSync Raises USD18 Million in Series B Financing 24

    Navigating Cancer Raises USD10 Million in Financing Round 25

    RaNA Therapeutics Raises USD55 Million in series B Financing 26

    MedCPU Raises USD8 Million in Financing Round 27

    ClearData Networks Raises USD25 Million in Series C Financing 28

    Liaison Technologies Raises Funds through Venture Financing 29

    Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30

    Aventura Raises USD14 Million in Series C Financing 31

    WiserTogether Raises USD9 Million in Series B Venture Financing 32

    Healthsense Raises USD10 Million in Venture Financing 33

    ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34

    ImaginAb Raises USD21 Million in Series B Venture Financing 35

    MedCPU Raises USD9.3 Million in Series B Financing 36

    AdvanDx Raises US Million In Series B-1 Venture Financing 37

    HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 38

    WellDoc Raises US.7 Million In Venture Financing 39

    ClearData Networks Raises US Million In Series B Financing 40

    GenomeDx Biosciences Raises Funds Through Series B Financing 41

    PatientSafe Solutions Raises US Million In Series C Venture Financing 42

    Aviir Raises US Million In Venture Financing 44

    eHealth Technologies Raises US Million In Series D Financing 46

    Remedy Informatics Raises US Million In Venture Financing 47

    Healthsense Raises US Million In Series D Financing 48

    Liaison Technologies Raises US Million In Venture Financing 49

    Physicians Interactive Holdings Secures US.5 Million In Venture Financing 50

    Private Equity 51

    Merck Global Health Acquires Physicians Interactive From Perseus 51

    Partnerships 52

    Merck Enters into Licensing Agreement with ImaginAb 52

    Cerveau Technologies Enters into Licensing Agreement with Merck 53

    Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 54

    Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 55

    HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 56

    CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 57

    OpGen Enters into Research Agreement with Merck 58

    Takeda Pharma Enters into Agreement with Koneksa Health 59

    Merck Enters into Co-Development Agreement with Amoy Diagnostics 60

    Enigma Biomedical Enters into Research Agreement with Biogen and Merck 61

    Merck to Enter into Co-Development Agreement with Biocartis 62

    Daktari Diagnostics Enters into Agreement with Merck 63

    Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 64

    Dako Enters into Agreement with Merck for Companion Diagnostic Test 65

    Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 66

    Physicians Interactive Enters Into Agreement With Greenway For eCoupon 67

    Merck Enters Into Co-Development Agreement With Geisinger Health System 68

    Perrigo Enters into Licensing Agreement with Merck 69

    Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 70

    Equity Offering 71

    OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 71

    VirtualScopics Completes First Tranche Of Private Placement Of Shares For US Million 73

    Debt Offering 74

    Merck Plans to Raise Funds through Public Offering of Debt Securities 74

    Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 75

    Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 76

    Acquisition 77

    OpGen Acquires AdvanDx 77

    Physicians Interactive Acquires Tomorrow Networks 78

    Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 79

    Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 81

    Merck & Co Inc - Key Competitors 82

    Merck & Co Inc - Key Employees 83

    Merck & Co Inc - Locations And Subsidiaries 85

    Head Office 85

    Other Locations & Subsidiaries 85

    Joint Venture 107

    Recent Developments 109

    Strategy And Business Planning 109

    Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 109

    Financial Announcements 110

    Jul 27, 2018: Merck Announces Second-Quarter 2018 Financial Results 110

    May 01, 2018: Merck Announces First-Quarter 2018 Financial Results 114

    Oct 27, 2017: Merck Announces Third-Quarter 2017 Financial Results 117

    Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 119

    May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 122

    Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 124

    Corporate Communications 126

    Mar 20, 2018: Merck Names Jennifer Zachary As General Counsel 126

    Jan 24, 2018: Merck Names Inge Thulin To Board Of Directors 127

    Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 128

    Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 129

    Government and Public Interest 130

    Jul 17, 2018: Merck Announces Future Insight Prize of up to € 1 Million for Groundbreaking Scientific Work 130

    Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 131

    Product News 132

    Aug 14, 2018: Geisinger and Merck unveil new applications developed to help improve patient communication and care delivery 132

    Other Significant Developments 134

    Oct 08, 2018: Merck’s novel Chemiflex raw materials program solves regulatory compliance challenges in small molecule drug manufacturing 134

    Sep 20, 2018: Merck publishes Corporate Responsibility Report 135

    Aug 15, 2018: Geisinger, Merck partner to launch EHR-Integrated FHIR Apps 136

    Jul 19, 2018: Merck Reinforces Commitment to Responsible Pricing 138

    Appendix 139

    Methodology 139

    About GlobalData 139

    Contact Us 139

    Disclaimer 139

List Of Tables
in Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Tables

Merck & Co Inc, Medical Equipment, Key Facts, 2017 2

Merck & Co Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Merck & Co Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9

Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Merck & Co Inc, Deals By Market, 2012 to YTD 2018 11

Merck & Co Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12

Grail Raises USD914 Million in First Tranche of Series B Financing 18

Livongo Health Raises USD44.5 Million in Series C Financing Round 21

WellDoc Raises USD22 Million in First Tranche of Series B Financing 23

CareSync Raises USD18 Million in Series B Financing 24

Navigating Cancer Raises USD10 Million in Financing Round 25

RaNA Therapeutics Raises USD55 Million in series B Financing 26

MedCPU Raises USD8 Million in Financing Round 27

ClearData Networks Raises USD25 Million in Series C Financing 28

Liaison Technologies Raises Funds through Venture Financing 29

Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30

Aventura Raises USD14 Million in Series C Financing 31

WiserTogether Raises USD9 Million in Series B Venture Financing 32

Healthsense Raises USD10 Million in Venture Financing 33

ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34

ImaginAb Raises USD21 Million in Series B Venture Financing 35

MedCPU Raises USD9.3 Million in Series B Financing 36

AdvanDx Raises US Million In Series B-1 Venture Financing 37

HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 38

WellDoc Raises US.7 Million In Venture Financing 39

ClearData Networks Raises US Million In Series B Financing 40

GenomeDx Biosciences Raises Funds Through Series B Financing 41

PatientSafe Solutions Raises US Million In Series C Venture Financing 42

Aviir Raises US Million In Venture Financing 44

eHealth Technologies Raises US Million In Series D Financing 46

Remedy Informatics Raises US Million In Venture Financing 47

Healthsense Raises US Million In Series D Financing 48

Liaison Technologies Raises US Million In Venture Financing 49

Physicians Interactive Holdings Secures US.5 Million In Venture Financing 50

Merck Global Health Acquires Physicians Interactive From Perseus 51

Merck Enters into Licensing Agreement with ImaginAb 52

Cerveau Technologies Enters into Licensing Agreement with Merck 53

Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 54

Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 55

HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 56

CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 57

OpGen Enters into Research Agreement with Merck 58

Takeda Pharma Enters into Agreement with Koneksa Health 59

Merck Enters into Co-Development Agreement with Amoy Diagnostics 60

Enigma Biomedical Enters into Research Agreement with Biogen and Merck 61

Merck to Enter into Co-Development Agreement with Biocartis 62

Daktari Diagnostics Enters into Agreement with Merck 63

Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 64

Dako Enters into Agreement with Merck for Companion Diagnostic Test 65

Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 66

Physicians Interactive Enters Into Agreement With Greenway For eCoupon 67

Merck Enters Into Co-Development Agreement With Geisinger Health System 68

Perrigo Enters into Licensing Agreement with Merck 69

Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 70

OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 71

VirtualScopics Completes First Tranche Of Private Placement Of Shares For US Million 73

Merck Plans to Raise Funds through Public Offering of Debt Securities 74

Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 75

Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 76

OpGen Acquires AdvanDx 77

Physicians Interactive Acquires Tomorrow Networks 78

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 79

Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 81

Merck & Co Inc, Key Competitors 82

Merck & Co Inc, Key Employees 83

Merck & Co Inc, Subsidiaries 85

Merck & Co Inc, Joint Venture 107

List Of Figures, Charts and Diagrams
in Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018]

List of Figures

Merck & Co Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Merck & Co Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8

Merck & Co Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9

Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10

Merck & Co Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

Additional Details

Publisher

Global Data

Publisher Information

Reference

225504 | GDME6319D

Number of Pages

139

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Merck & Co Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Merck KGaA / Merck Serono Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review
Merck KGaA (MRK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic S...
01 Mar 2016 by Global Data USD $125 More Info
Merck Serono S.A. - Medical Equipment - Deals and Alliances Profile
SummaryMerck Serono S.A., (Merck Serono) is the biopharmaceutical division of Merck KGaA. It discove...
24 Feb 2016 by Global Data USD $250 More Info
Merck KGaA (MRK) - Medical Equipment - Deals and Alliances Profile
SummaryMerck KGaA (Merck) is a pharmaceutical and chemical company, which operates its business in t...
24 Feb 2016 by Global Data USD $250 More Info
PT Merck Tbk (MERK) - Financial and Strategic SWOT Analysis Review
SummaryPT Merck Tbk (Merck), a subsidiary of Merck KGaA is a pharmaceutical and chemical company tha...
09 Jan 2016 by Global Data USD $300 More Info
Pt Merck Sharp Dohme Pharma Tbk (SCPI) - Financial and Strategic SWOT Analysis Review
SummaryPt Merck Sharp Dohme Pharma Tbk (MSD) is a pharmaceutical company. The company researches, de...
09 Jan 2016 by Global Data USD $300 More Info
PT Merck Tbk (MERK) - Financial and Strategic SWOT Analysis Review
SummaryPT Merck Tbk (Merck), a subsidiary of Merck KGaA is a pharmaceutical and chemical company tha...
08 Nov 2015 by Global Data USD $300 More Info
Pt Merck Sharp Dohme Pharma Tbk (SCPI) - Financial and Strategic SWOT Analysis Review
SummaryPt Merck Sharp Dohme Pharma Tbk (MSD) is a pharmaceutical company. The company researches, de...
08 Nov 2015 by Global Data USD $300 More Info
Physician Views: The PD-1 inhibitor class lands – how do US oncologists expect to initially use Merck & Co.'s Keytruda?
Scope As many were expecting, approval of Merck & Co.'s pembrolizumab – now branded as Keytruda – ca...
09 Sep 2014 by FirstWord Pharma USD $695 More Info

This report is published by Global Data

Download Free Report Summary PDF

Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile [Report Updated: 16-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data